Literature DB >> 21284077

The successful integration of research and care: how pediatric oncology became the subspecialty in which research defines the standard of care.

Yoram Unguru1.   

Abstract

Pediatric oncology successfully embodies the integration of patient care with medical research. Several factors may explain this phenomenon. Specifically, the study of childhood leukemia provided scientists with principles by which they could approach other forms of cancer. Multicenter, cooperative group RCTs resulted in meaningful advances. Parents' often desperate hope for a cure, combined with clinician-investigators efforts to continually improve upon treatments resulted in important improvements in children's lives. Finally, the seemingly tolerant regulatory oversight of human subjects research in the early years of childhood cancer research paradoxically helped link research with care, thus solidifying this bond for years to come.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21284077     DOI: 10.1002/pbc.22976

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  10 in total

1.  Predictors of Success of Phase II Pediatric Oncology Clinical Trials.

Authors:  Laura Franshaw; Maria Tsoli; Jennifer Byrne; Chelsea Mayoh; Siva Sivarajasingam; Murray Norris; Glenn M Marshall; David S Ziegler
Journal:  Oncologist       Date:  2019-02-26

2.  Hospital Variation in Intensive Care Resource Utilization and Mortality in Newly Diagnosed Pediatric Leukemia.

Authors:  Julie C Fitzgerald; Yimei Li; Brian T Fisher; Yuan-Shung Huang; Tamara P Miller; Rochelle Bagatell; Alix E Seif; Richard Aplenc; Neal J Thomas
Journal:  Pediatr Crit Care Med       Date:  2018-06       Impact factor: 3.624

3.  Ethical issues for control-arm patients after revelation of benefits of experimental therapy: a framework modeled in neuroblastoma.

Authors:  Yoram Unguru; Steven Joffe; Conrad V Fernandez; Alice L Yu
Journal:  J Clin Oncol       Date:  2013-01-07       Impact factor: 44.544

4.  Toxicity and efficacy of the acetylcholinesterase (AChe) inhibitor donepezil in childhood brain tumor survivors: a pilot study.

Authors:  Sharon M Castellino; Janet A Tooze; Lynn Flowers; Debbie F Hill; Kevin P McMullen; Edward G Shaw; Susan K Parsons
Journal:  Pediatr Blood Cancer       Date:  2012-01-11       Impact factor: 3.167

5.  Increasing value and reducing waste in biomedical research regulation and management.

Authors:  Rustam Al-Shahi Salman; Elaine Beller; Jonathan Kagan; Elina Hemminki; Robert S Phillips; Julian Savulescu; Malcolm Macleod; Janet Wisely; Iain Chalmers
Journal:  Lancet       Date:  2014-01-08       Impact factor: 79.321

6.  Designing clinical trials in trauma surgery: overcoming research barriers.

Authors:  D C Perry; X L Griffin; N Parsons; M L Costa
Journal:  Bone Joint Res       Date:  2014-04-24       Impact factor: 5.853

7.  Pediatric oncology as a Learning Health System: Ethical implications for best available treatment protocols.

Authors:  Rieke van der Graaf; Sara A Dekking; Martine C de Vries; Christian Michel Zwaan; Johannes J M van Delden
Journal:  Learn Health Syst       Date:  2018-04-16

Review 8.  Pharmacogenomic testing in paediatrics: Clinical implementation strategies.

Authors:  Charlotte I S Barker; Gabriella Groeneweg; Anke H Maitland-van der Zee; Michael J Rieder; Daniel B Hawcutt; Tim J Hubbard; Jesse J Swen; Bruce C Carleton
Journal:  Br J Clin Pharmacol       Date:  2022-02-07       Impact factor: 3.716

9.  Do health care institutions value research? A mixed methods study of barriers and facilitators to methodological rigor in pediatric randomized trials.

Authors:  Michele P Hamm; Shannon D Scott; Terry P Klassen; David Moher; Lisa Hartling
Journal:  BMC Med Res Methodol       Date:  2012-10-18       Impact factor: 4.615

10.  Advanced targeted, cell and gene-therapy approaches for pediatric hematological malignancies: results and future perspectives.

Authors:  Chiara F Magnani; Sarah Tettamanti; Francesca Maltese; Nice Turazzi; Andrea Biondi; Ettore Biagi
Journal:  Front Oncol       Date:  2013-04-30       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.